Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis

被引:39
作者
Chasset, Francois [1 ]
Frances, Camille [1 ]
机构
[1] Univ Pierre & Marie Curie Paris VI, Hop Tenon, AP HP, Serv Dermatol Allergol, 4 Rue Chine, F-75020 Paris, France
关键词
Takayasu arteritis; Giant-cell arteritis; Polyarteritis nodosa; Kawasaki disease; GIANT-CELL ARTERITIS; SYSTEMIC-NECROTIZING-VASCULITIDES; PLACEBO-CONTROLLED TRIAL; OF-THE-LITERATURE; POLYARTERITIS-NODOSA; TAKAYASU ARTERITIS; KAWASAKI-DISEASE; DOUBLE-BLIND; DIAGNOSTIC-CRITERIA; SCALP NECROSIS;
D O I
10.1007/s12016-017-8612-9
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Dermatologic manifestations are observed in almost all systemic vasculitides, even in large-and medium-vessel vasculitides, although such vessels are not found in the skin. Cutaneous manifestations may be related to a direct skin localization of the systemic vasculitis or a non-specific process associated with the vasculitis. According to the 2012 International Chapel Hill consensus, the two major variants of large-vessel vasculitides are Takayasu arteritis and giant-cell arteritis. In Europe and North America, acute inflammatory nodules or erythema nodosum-like lesions are the most commonly observed skin lesions with Takayasu arteritis. Medium-sized arteriole vasculitis of the dermis or subcutis but also septal or lobular panniculitis may be found during pathological examination. In Japan, widespread pyoderma gangrenosum-like lesions are more frequent. Cutaneous manifestations of giant-cell arteritis are rare; they are ischemic, linked to arterial occlusions, or non-ischemic, with various mechanisms. The two major medium-vessel vasculitides are Kawasaki disease and polyarteritis nodosa. Kawasaki disease is characterized by a mucocutaneous lymph node syndrome without skin vasculitis. Two subsets of polyarteritis nodosa with different skin manifestations are described, without transition from one to the other. In the systemic subset, the most frequent skin lesions are in the order of frequency purpura, livedo, and nodules. Cutaneous polyarteritis nodosa mainly features nodules, livedo racemosa, and ulcerations. Genetic screening and measurement of plasma levels of adenosine deaminase 2 should be considered for patients with uncommon systemic polyarteritis nodosa or early-onset cutaneous polyarteritis nodosa.
引用
收藏
页码:452 / 468
页数:17
相关论文
共 50 条
[41]   Cellular Signaling Pathways in Medium and Large Vessel Vasculitis [J].
Watanabe, Ryu ;
Berry, Gerald J. ;
Liang, David H. ;
Goronzy, Jorg J. ;
Weyand, Cornelia M. .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[42]   Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature [J].
Koetter, I. ;
Henes, J. C. ;
Wagner, A. D. ;
Loock, J. ;
Gross, W. L. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (01) :S114-S129
[43]   Tocilizumab: a new therapy for large vessel vasculitis [J].
Al-Homood, Ibrahim A. .
CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 14 (04) :355-360
[44]   A Long-term Persistent Vascular Fluorodeoxyglucose Uptake in a Patient with Large-vessel Vasculitis [J].
Ie, Kenya ;
Sakai, Tsubasa ;
Kurosu, Eri ;
Motohashi, Iori ;
Yagihashi, Kunihiro ;
Okuse, Chiaki ;
Matsuda, Takahide .
INTERNAL MEDICINE, 2022, 61 (03) :357-360
[45]   Neutrophil activation in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis and large-vessel vasculitis [J].
Michailidou, Despina ;
Duvvuri, Bhargavi ;
Kuley, Runa ;
Cuthbertson, David ;
Grayson, Peter C. ;
Khalidi, Nader A. ;
Koening, Curry L. ;
Langford, Carol A. ;
McAlear, Carol A. ;
Moreland, Larry W. ;
Pagnoux, Christian ;
Seo, Philip ;
Specks, Ulrich ;
Sreih, Antoine G. ;
Warrington, Kenneth J. ;
Mustelin, Tomas ;
Monach, Paul A. ;
Merkel, Peter A. ;
Lood, Christian .
ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
[46]   Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update [J].
Pipitone, N. ;
Versari, A. ;
Salvarani, C. .
RHEUMATOLOGY, 2008, 47 (04) :403-408
[47]   Update on Outcome Measure Development in Large-vessel Vasculitis: Report from OMERACT 2018 [J].
Aydin, Sibel Z. ;
Robson, Joanna C. ;
Sreih, Antoine G. ;
Hill, Catherine ;
Alibaz-Oner, Fatma ;
Mackie, Sarah ;
Beard, Susan ;
Gul, Ahmet ;
Hatemi, Gulen ;
Kermani, Tanaz A. ;
Mahr, Alfred ;
Meara, Alexa ;
Milman, Nataliya ;
Shea, Beverley ;
Tomasson, Gunnar ;
Tugwell, Peter ;
Direskeneli, Haner ;
Merkel, Peter A. .
JOURNAL OF RHEUMATOLOGY, 2019, 46 (09) :1198-1201
[48]   18-FDG PET for large-vessel vasculitis diagnosis and follow-up [J].
Angelotti, F. ;
Capecchi, R. ;
Giorgetti, A. ;
Erba, P. A. ;
Genovesi, D. ;
Emdin, M. ;
Barison, A. ;
Manca, L. ;
Rocchi, V ;
Migliorini, P. ;
Tavoni, A. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (02) :S76-S82
[49]   Cutaneous manifestations in systemic vasculitis [J].
Irene Decleva ;
Angelo Valerio Marzano ;
Mauro Barbareschi ;
Emilio Berti .
Clinical Reviews in Allergy & Immunology, 1997, 15 :5-20
[50]   Ultrasonographic resolution of the vessel wall oedema with modest clinical improvement in a large-vessel vasculitis patient treated with tocilizumab [J].
Besada, Emilio ;
Nossent, Johannes C. .
CLINICAL RHEUMATOLOGY, 2012, 31 (08) :1263-1265